Financial Performance
5Y price score: 117
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 208.2%
US$ Per
Share
By default your notes are visible only to you.
127.8
52-week range
191.5
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
11.2 %
Dividend Yield TTM
0.7 %
Market cap $
$ 14,028
Price / Earnings TTM
12
Price / Book TTM
2.3
PEG TTM
0.7
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
30.7 %
92.1 %
208.2 %
Free cash flow per share growth
(1.3) %
15.9 %
81.5 %
Earnings per share growth
17.8 %
106.2 %
238 %
Founded: 1,900
Employees: 3,732
Business Summary:
Latest Earnings Call Takeaways
2026 Q2 (Jul 23, 2026)
1) Financial Performance Highlights - Net income for Q2 2026 was $288 million, or $3.65 per share, a 20% increase from $3.05 per share a year ago. - Net operating income was $285 million, or $3.61 per share, up 10% from $3.27 per share in the prior year. - Total premium revenue grew 7% YoY, with life premium revenue increasing 3% to $861 million and health premium revenue rising 16% to $437 million. - The return on equity was 18.4%, with book value per share at $70.18, up 11% YoY.
2) Segment Insights and Operational Strategies - Life underwriting margin was 42%, up from 41% YoY, with expectations to reach over 50% in Q3 due to assumption updates. - Health underwriting margin was approximately 23%, down from 26% YoY, with full-year expectations between 23% to 27%. - The company is implementing AI applications to improve operational efficiencies, particularly in customer service and sales processes.
3) Challenges and Headwinds - American Income Life saw a 2% decline in net life sales due to a 7% drop in average producing agent count, although there was a 3% sequential increase from Q1. - Direct-to-consumer (DTC) sales decreased 15% YoY, attributed to a shift in consumer search behavior and increased competition in online advertising. - Health obligations as a percent of premium rose to 56.8%, higher than estimates, driven by prior period claims and adverse fluctuations in high severity claims.
4) Guidance and Future Outlook - For the full year 2026, net operating earnings per diluted share are expected to be between $15.55 to $15.95, reflecting 8.5% growth at the midpoint. - Health premium revenue is anticipated to grow 14% to 16%, with United American's health margin expected to be around 7% in the second half. - The company plans to return approximately $350 million to $370 million to shareholders through dividends and share repurchases, with share repurchases projected at $670 million to $700 million.
5) Conclusion and Missing Information - The call provided comprehensive insights into financial performance, operational strategies, and future guidance. However, specific details on the impact of AI on sales growth and the timeline for the Bermuda subsidiary's capital contributions were less clear.
Bottom line: Globe Life Inc. is positioned for continued growth with strong financial performance and strategic investments in AI, despite facing challenges in agent recruitment and DTC sales. The outlook for 2026 remains positive, with expectations for solid earnings growth and shareholder returns.
Annual Reports, Presentations And IR Contacts
Go to the websiteGlobe Life — Financial Overview, Stock Price, Market Cap
Globe Life is a company. Founded in 1900. As of August 14, 2026, the company's market capitalization is $14028086016 with a current stock price of $180.67.